No Data
No Data
TD Cowen Maintains Allurion Technologies(ALUR.US) With Buy Rating, Cuts Target Price to $16
Allurion Technologies (ALUR) Receives a Buy From TD Cowen
12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session
Allurion Technologies Enhances Financial Agreements and Governance
Allurion Announces Positive Topline Results From AUDACITY Trial; At 48 Weeks, Allurion Balloon Subjects Had A Greater Than 50% Responder Rate And Substantially Greater Weight Loss Than Control Subjects
Express News | Allurion: Fourth and Final Module of Pma Submission Including Audacity Trial Data Planned for 2025
Unlock the Full List